INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 115 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is 2.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $144,000 | +28.6% | 31,257 | -2.7% | 0.00% | – |
Q4 2018 | $112,000 | -56.8% | 32,129 | +25.2% | 0.00% | – |
Q3 2018 | $259,000 | +324.6% | 25,667 | +205.0% | 0.00% | – |
Q2 2018 | $61,000 | +17.3% | 8,415 | -2.0% | 0.00% | – |
Q1 2018 | $52,000 | -72.0% | 8,588 | -55.5% | 0.00% | – |
Q4 2017 | $186,000 | -39.0% | 19,310 | -43.7% | 0.00% | – |
Q3 2017 | $305,000 | -10.8% | 34,315 | +26.8% | 0.00% | – |
Q2 2017 | $342,000 | -21.4% | 27,066 | -34.7% | 0.00% | – |
Q1 2017 | $435,000 | -79.2% | 41,474 | -81.7% | 0.00% | – |
Q4 2016 | $2,090,000 | +1331.5% | 227,136 | +1731.7% | 0.00% | – |
Q3 2016 | $146,000 | -84.9% | 12,400 | -83.4% | 0.00% | – |
Q2 2016 | $967,000 | -6.2% | 74,725 | +15.9% | 0.00% | – |
Q1 2016 | $1,031,000 | -26.6% | 64,487 | +31.3% | 0.00% | – |
Q4 2015 | $1,405,000 | -23.5% | 49,109 | -23.8% | 0.00% | – |
Q3 2015 | $1,836,000 | +104.5% | 64,474 | +157.9% | 0.00% | – |
Q2 2015 | $898,000 | +224.2% | 24,999 | +425.1% | 0.00% | – |
Q1 2015 | $277,000 | +35.1% | 4,761 | -2.4% | 0.00% | – |
Q4 2014 | $205,000 | +18.5% | 4,876 | +9.6% | 0.00% | – |
Q3 2014 | $173,000 | -58.2% | 4,448 | -66.4% | 0.00% | – |
Q2 2014 | $414,000 | +111.2% | 13,253 | +179.4% | 0.00% | – |
Q1 2014 | $196,000 | -96.0% | 4,743 | -96.3% | 0.00% | -100.0% |
Q4 2013 | $4,926,000 | +2978.8% | 127,254 | +2677.3% | 0.00% | – |
Q3 2013 | $160,000 | +68.4% | 4,582 | -33.1% | 0.00% | – |
Q2 2013 | $95,000 | – | 6,849 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |